Tent – canopy – umbrella – or cane – Umbrella – Self-opening and closing
Patent
1993-04-29
1996-05-14
Walsh, Stephen G.
Tent, canopy, umbrella, or cane
Umbrella
Self-opening and closing
435 691, 4353201, 530350, 536 235, C07K 14705, C12N 1512
Patent
active
055166830
ABSTRACT:
The present invention is directed toward the isolation, characterization and pharmacological use of the human D4 dopamine receptor. The nucleotide sequence of the gene corresponding to this receptor and alleleic variants thereof are provided by the invention. The invention particularly provides recombinant eukaryotic expression constructs capable of expressing the human D4 dopamine receptor at useful levels in cultures of transformed eukaryotic cells. The invention provides cultures of transformed eukaryotic cells which synthesize such useful amounts of human D4 dopamine receptor protein, and methods for characterizing novel psychotropic compounds using such cultures.
REFERENCES:
FEBS Let. 243:371-6, Jan. 1989, Deckmann et al Monoclonal Antibodies against the S.sub.2 -serotonin receptor from rat brain that cross-react with . . . .
Ackenheil et al., 1976, "Antipsychotische wirksamkeit im verhaltnis zum plasmaspiegel von clozapin", Arzneim-Forsch 26: 1156-1158 teach the relationships between the administered dosage, plasma levels and psychological effects of clozapine in schizophrenics.
Cooper et al., 1978, "Catecholamines II: CNS aspects", The Biochemical Basis of Neuropharmacology, 3d ed., Oxford University Press, New York, pp. 161-195.
Kebabian & Calne, 1979, "Multiple receptors for dopamine", Nature 277: 93-96.
Botstein et al., 1980, "Construction of a genetic linkage map in man using restriction fragment length polymorphisms", Am. J. Hum. Genet. 32: 314-331.
Amlaiky & Caron, 1985, "Photoaffinity labeling of the D.sub.2 -dopamine receptor using a novel high affinity radioiodinated probe", J. Biol. Chem. 260: 1983-1986.
Amlaiky & Caron, 1986, "Identification of the D.sub.2 -dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling", J. Neurochem. 47: 196-204.
Senogles et al., 1986, "Affinity chromatography of the anterior pituitary D.sub.2 -dopamine receptor", Biochemistry 25: 749-753.
Amlaiky et al., 1987, "Identification of the binding subunit of the D.sub.1 -dopamine receptor by photoaffinity crosslinking", Mol. Pharmacol. 31: 129-134.
Seeman et al., 1987, "Human brain D.sub.1 and D.sub.2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases", Neuropsychopharm. 1: 5-15.
Seeman, 1987, "Dopamine receptors and the dopamine hypothesis of schizophrenia", Synapse 1: 152-333.
Jarvie et al., 1988, "Dopamine D.sub.2 receptor binding subunits of M.sub.r .apprxeq.140,000 and 94,000 in brain: deglycosylation yields a common unit of.apprxeq.44,000", Mol. Pharmacol. 34: 91-97.
Niznik et al., 1988, "Photoaffinity labeling of dopamine D.sub.1 receptors", Biochemistry 27: 7594-7599.
Sengoles et al., 1988, "Purification and characterization of the D.sub.2 -dopamine receptor from bovine anterior pituitary", J. Biol. Chem. 263: 18996-19002.
Gingrich et al., 1988, "Affinity chromatography of the D.sub.1 dopamine receptor from rat Corpus striatum", Biochemistry 27: 3907-3912.
Bunzow et al., 1988, "C,loning and expression of a rat D.sub.2 dopamine receptor cDNA", Nature 336: 783-787.
Grandy et al., 1989, "Cloning of the cDNA and gene for a human D.sub.2 dopamine receptor", Proc. Natl. Acad. Sci. USA 86: 9762-9766.
Dal Toso et al., 1989, "The dopamine D.sub.2 receptor: two molecular forms generated by alternative splicing", EMBO J. 8: 4025-4034.
Casey, 1989, "Clozapine: neuroleptic-induced EPS and tardive dyskinesia", Psychopharmacology 99: 547-553.
Zhou et al., 1990, "Cloning and expression of human and rat D.sub.1 dopamine receptors", Nature 346: 76-80.
Sunahara et al., 1990, "Human dopamine D.sub.1 receptor encoded by an intronless gene on chromosome 5", Nature 346: 80-83.
Sokoloff et al., 1990, "Molecular cloning and characterization of a novel dopamine receptor (D.sub.3) as a target for neuroleptics", Nature 347: 146-151.
Kane et al., 1990, "Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine", Arch. Gen. Psychiatry 45: 789-796.
Sandoz Canada, Inc., 1990, Clozaril: Summary of preclinical and clinical data.
Van Tol et al., 1991, "Cloning of the gene for a human dopamine D.sub.4 receptor with a high affinity for the antipsychotic clozapine", Nature 350: 610-614.
Sunahara et al., 1991, "Cloning of the gene for a human dopamine D.sub.5 receptor with higher affinity for dopamine than D.sub.1 ", Nature 350: 614-619.
Van Tol et al., 1992, "Multiple domain D4 receptor variants in the human population", Nature 358: 148-152.
Fishburn et al., 1993, "A novel short isoform of the D.sub.3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop", J. Biol. Chem. 268: 5872-5878.
Boundy et al., 1993, "Expression and characterization of the rat D3 dopamine receptor: Pharamacologic properties and development of antibodies", J. Pharmacol. Exper. Therap. 264: 1002-1011.
Bunzow James R.
Civelli Olivier
Grandy David K.
Van Tol Hubert H.-M.
State of Oregon Acting by and Through the Oregon State Board of
Uim John D.
Walsh Stephen G.
LandOfFree
Human D4 dopamine receptor and its uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human D4 dopamine receptor and its uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human D4 dopamine receptor and its uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895169